|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01419 HUMAN HEALTH
Nominal 
0.790 0.000 (0.000%) | 2024/06 - Final HKD(K$) | %Chg (Compare to Final) | 2023/06 HKD(K$) | 2022/06 HKD(K$) | 2021/06 HKD(K$) | 2020/06 HKD(K$) | |
| Turnover | 590,819 | -41.021% | 1,001,746 | 1,121,793 | 654,712 | 453,737 |
| Cost of Sales | (320,968) | -21.430% | (408,510) | (462,108) | (278,023) | (263,898) |
| Gross Profit | 269,851 | -54.512% | 593,236 | 659,685 | 376,689 | 189,839 |
| 2024/06 - Final HKD(K$) | %Chg (Compare to Final) | 2023/06 HKD(K$) | 2022/06 HKD(K$) | 2021/06 HKD(K$) | 2020/06 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | (4,677) | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (1,271) | -17.628% | (1,543) | (1,977) | 990 | (1,143) | |
| Profit / (Loss) before Taxation | 26,564 | -88.877% | 238,816 | 445,262 | 168,820 | (39,012) | |
| Taxation | (2,375) | -95.904% | (57,977) | (69,953) | (24,367) | (1,362) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 24,189 | -86.624% | 180,839 | 375,309 | 144,453 | (40,374) | |
| 2024/06 - Final HKD(K$) | %Chg (Compare to Final) | 2023/06 HKD(K$) | 2022/06 HKD(K$) | 2021/06 HKD(K$) | 2020/06 HKD(K$) | |
| Net Finance Costs / (Income) | (8,932) | 4504.124% | (194) | 2,735 | 2,639 | 3,036 |
| Depreciation & Amortisation | 68,009 | -9.067% | 74,790 | 63,074 | 67,598 | 75,333 |
| Directors' Emoluments | 13,214 | -31.367% | 19,253 | 13,049 | 9,738 | 8,488 |
| 2024/06 - Final | %Chg (Compare to Final) | 2023/06 | 2022/06 | 2021/06 | 2020/06 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2024/06 - Final | %Chg (Compare to Final) | 2023/06 | 2022/06 | 2021/06 | 2020/06 | |
| EPS (cts) | 6.400 | -86.555% | 47.600 | 98.900 | 38.100 | -10.600 |
| DPS (cts) | 2.800 | -- | 16.000 | 30.000 | 12.000 | 0.000 |
| Dividend Payout Ratio (%) | 43.750% | -- | 33.613% | 30.334% | 31.496% | -- |
| Cash flow per share ($) | 0.035 | -- | 1.750 | 0.779 | 0.225 | 0.099 |
| NBV per share ($) | 2.020 | -- | 2.129 | 1.955 | 1.081 | 0.683 |
| Remarks: | Real time quote last updated: 28/11/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders ($) | HKD 24,189,000 |
| %Change | -86.624% |
| EPS / (LPS) | HKD 0.064 |
| NBV Per Share ($) | HKD 2.020 |